Elafin has been reported to inhibit the proliferation of breast cancer cells instead of normal cells [36], and during the tumorigenesis of breast cancer, elafin was shown to be downregulated in invasive breast cancer compared to normal mammary epithelium [37]. Here, PI3 is linked to invasive breast carcinoma.